Advertisement
News
Advertisement

InVivo Therapeutics ends 2011 with $34.7M net loss

Thu, 03/15/2012 - 12:36pm
Mass High Tech: The Journal of New England Technology

InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), which develops technologies for treatment of spinal cord injuries, reported a net loss of $34.7 million, or $0.67 per diluted share, for the year ending Dec. 31, 2011.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading